14735-70-7

Basic information

• Product Name: 3-AZA-TRICYCLO[4.2.1.0(2,5)]NON-7-EN-4-ONE
• Synonyms: 4-OXO-3-AZA-TRICYCLO[4.2.1.0(2.5)]NON-7-ENE;3-AZA-TRICYCLO[4.2.1.0(2,5)]NON-7-EN-4-ONE;NORBORNENE AZETIDINONE;Cis-3-Azatricyclo[4.2.1.02,5]Non-7-En-4-One;Cis-3-Azatricyclo[4.2.1.02,5]Non-7-En-4-One(WX106122)
• CAS NO: 14735-70-7
• Molecular Formula: C₈H₉NO
• Molecular Weight: 135.16
• Mol File: 14735-70-7.mol
• Article Data: 7

Chemical Properties

• Melting Point: 117-122 °C
• Boiling Point: 248.86°C (rough estimate)
• Flash Point: 189.967 °C
• Appearance: Slightly beige/Needle-Like Crystalline Powder
• Density: 1.1031 (rough estimate)
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.5635 (rough estimate)
• Storage Temp.: 0-6°C
• PKA: 15.24±0.20(Predicted)
• CAS DataBase Reference: 3-AZA-TRICYCLO[4.2.1.0(2,5)]NON-7-EN-4-ONE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-AZA-TRICYCLO[4.2.1.0(2,5)]NON-7-EN-4-ONE(14735-70-7)
• EPA Substance Registry System: 3-AZA-TRICYCLO[4.2.1.0(2,5)]NON-7-EN-4-ONE(14735-70-7)

Safety Data

• Safety Statements: 24/25
• Hazardous Substances Data: 14735-70-7(Hazardous Substances Data)

Usage

General Description

3-AZA-TRICYCLO[4.2.1.0(2,5)]NON-7-EN-4-ONE is a chemical compound with a complex structure that includes a tricyclic ring system and a ketone functional group. It is a heterocyclic compound that contains a nitrogen atom in the ring and belongs to the amine and amide class of organic compounds. This chemical may have potential applications in pharmaceutical and medicinal chemistry due to its unique structure and potential biological activity. The synthesis and study of 3-AZA-TRICYCLO[4.2.1.0(2,5)]NON-7-EN-4-ONE and its derivatives could contribute to the development of new drugs and therapeutic agents. Additionally, its unique ring system makes it an interesting target for chemical synthesis and research in the field of organic chemistry.

InChI:InChI=1/C8H9NO/c10-8-6-4-1-2-5(3-4)7(6)9-8/h1-2,4-7H,3H2,(H,9,10)/t4-,5+,6+,7-/m0/s1

Upstream product

• 121-46-0 bicyclo[2.2.1]hepta-2,5-diene 
• 1189-71-5 isocyanate de chlorosulfonyle 
• 14805-30-2 4-oxo-(1rC⁹,2tH,5tH,6cC⁹)-3-aza-tricyclo[4.2.1.0^2,5]non-7-ene-3-sulfonyl chloride 
• 121-46-0 bicyclo[2.2.1]hepta-2,5-diene 

Downstream Products

• 92511-32-5 3-exo-aminobicyclo[2.2.1]hept-5-ene-2-exo-carboxylic acid 
• 106690-56-6 2-(3-chlorophenyl)-pyrimidin-4-one 
• 106690-53-3 2-Cyclohexyl-3H-pyrimidin-4-one 
• 106690-57-7 2-p-tolyl-3H-pyrimidin-4-one 
• 106690-54-4 2-(4-Chloro-benzyl)-3H-pyrimidin-4-one 
• 113094-20-5 3-(p-chlorophenyl)carbamoylaza-4-oxotetracyclo<4.2.1.0>non-7-ene 
• 33643-94-6 4-oxo-2-phenyl-3,4-dihydropyrimidine 
• 106690-55-5 2-(4-chlorophenyl)-3H-pyrimidin-4-one 
• 113094-21-6 3-(m-chlorophenyl)carbamoylaza-4-oxotetracyclo<4.2.1.0>non-7-ene 
• 924272-78-6 (1S,2S,5R,6R)-exo-3-azatricyclo[4.2.1.0(2,5)]non-7-en-4-one 
• 202187-27-7 (1S,2S,3R,4R)-3-exo-aminobicyclo[2.2.1]hept-5-ene-2-exo-carboxylic acid 
• 924272-78-6 (1R,2R,5S,6S)-3-azatricyclo[4.2.1.0^2,5]non-7-en-4-one 
• 202187-27-7 (1R,2R,3S,4S)-3-exo-aminobicyclo[2.2.1]hept-5-ene-2-exo-carboxylic acid 
• 947601-81-2 (1S,2S,3R,4R)-3-Amino-bicyclo[2.2.1]hept-5-ene-2-carboxylic acid; hydrochloride 

Relevant articles and documents

Diversity-oriented Functionalization of Cyclodienes Through Selective Cycloaddition/Ring-opening/Cross-metathesis Protocols; Transformation of a “Flatland” into Three-dimensional Scaffolds With Stereo- and Regiocontrol

This article presents selective transformations of some readily available cyclodienes through simple chemical procedures into novel functionalized small-molecular entities. The syntheses hereby described involved selective cycloadditions, followed by ring

PROCESS FOR MAKING BETA 3 AGONISTS AND INTERMEDIATES

The present invention is directed to processes for preparing beta 3 agonists of Formula (I) and Formula (II) and their intermediates. The beta 3 agonists are useful in the treatment of certain disorders, including overactive bladder, urinary incontinence, and urinary urgency.

[1,2,4]THIADIAZINE 1,1-DIOXIDE COMPOUNDS

The invention is directed to [1,2,4]thiadiazine 1,1-dioxide compounds and pharmaceutical compositions containing such compounds that are useful in treating infections by hepatitis C virus.